Hep C Drug Stocks in the Spotlight

Description:

According to Adam Feuerstein, "Biotech and drug investors with interest in emerging treatments for hepatitis C turn their attention this week to the European Association for the Study of the Liver (EASL) annual meeting, which kicks off Weds. March 30." Read more here.

>>Also: Top-Rated Biotech Stocks

>>Also: 40 Stocks Analysts Are Insanely Bullish About

Most Viewed Portfolios

View All

Articles

5 Rocket Stocks to Buy for August Gains

07.28.14 | 09:57 AM

BALTIMORE (Stockpickr) -- It may be hard to believe, but August trading kicks off on Friday. That means that investors need to be buckling in for t...

3 Stocks Spiking on Big Volume

07.28.14 | 07:27 AM

DELAFIELD, Wis. (Stockpickr) -- Professional traders running mutual funds and hedge funds don't just look at a stock's price moves; they also track...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter